{"id":"W3046400044","doi":"10.1093/annonc/mdx814","title":"Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma","year":2018,"lang":"en","type":"erratum","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Nutrition, Metabolism and Diabetes","funders":"National Cancer Institute; Wyeth Pharmaceuticals; National Institutes of Health","keywords":"Mantle cell lymphoma; Medicine; Temsirolimus; Cladribine; Rituximab; Internal medicine; Oncology; Clinical trial; Family medicine; Randomized controlled trial; Regimen; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001530639,0.0003628167,0.0005993913,0.0002321809,0.0002648664,0.0005456335,0.0003980601,0.0008401077,0.01573788],"category_scores_gemma":[0.001846344,0.0002099383,0.0005132914,0.0001864998,0.0002516197,0.0004661033,0.000218498,0.002369656,0.001842195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004125733,"about_ca_system_score_gemma":0.000893006,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003538182,"about_ca_topic_score_gemma":0.0009856246,"domain_scores_codex":[0.9996895,0.0001561799,0.0000295662,0.00003353442,0.00004316706,0.0000482083],"domain_scores_gemma":[0.999397,0.0002486681,0.00007171716,0.00003911109,0.00006491798,0.0001784854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5174649,0.02280805,0.003330851,0.001105376,0.0007680748,0.0008926735,0.0003157492,0.0008630855,0.0148284,0.001732896,0.1504484,0.2854416],"study_design_scores_gemma":[0.6621659,0.1921265,0.009172345,0.0003252925,0.0005473308,0.0008891023,0.00007018278,0.001085716,0.006364146,0.000576164,0.126646,0.00003126329],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.7930423,0.02939328,0.003869264,0.03438449,0.01789037,0.01327016,0.01594095,0.000554513,0.0916546],"genre_scores_gemma":[0.8796942,0.01092856,0.008631981,0.01314492,0.002613771,0.004859986,0.01607678,0.0001278676,0.06392202],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01573788,"threshold_uncertainty_score":0.05264848,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1186129518352628,"score_gpt":0.436661129180119,"score_spread":0.3180481773448561,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}